Fierce Biotech

Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA

Published

2 weeks ago

on

Biopharma funding fell 20% last year, reversing the post-pandemic recovery as the IPO haul dropped to the lowest level of the past 10 years, according to an IQVIA analysis.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version